SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc., (NASDAQ: BIAF; BIAFW) will present results of its research into the use of flow cytometry for analyzing the lung environment to detect ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
Recently these monocyte-derived alveolar macrophages, or Mo-AMs, were identified as key drivers of lung fibrosis disease progression. However, the mechanisms of their pro-fibrotic behavior and ...
Researchers at the University of Liège (Belgium) have discovered a new population of macrophages, important innate immune cells that populate the lungs after injury caused by respiratory viruses.
At the height of the SARS-CoV-2 pandemic, researchers in Thomas Marichal’s immunophysiology laboratory at the University of Liège were studying samples collected from the lungs of patients who had ...
Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to immunosuppression and cancer ...
Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, it has infected over 525 million people worldwide and caused almost 6.3 million deaths. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback